104 related articles for article (PubMed ID: 11852924)
1. Immunohistochemical analysis of transforming growth factor beta 3 expression in solitary morphoea profunda with histological membranocystic changes.
Kawakami T; Soma Y; Baba T; Mizoguchi M; Matsuzaki K; Kumagai N
Br J Dermatol; 2002 Jan; 146(1):171-3. PubMed ID: 11852924
[No Abstract] [Full Text] [Related]
2. Analysis of dendritic cell populations using a revised histological staging of morphoea.
Gilmour TK; Wilkinson B; Breit SN; Kossard S
Br J Dermatol; 2000 Dec; 143(6):1183-92. PubMed ID: 11122019
[TBL] [Abstract][Full Text] [Related]
3. Perforating plate-like osteoma cutis in a man with solitary morphoea profunda.
Ahn SK; Won JH; Choi EH; Kim SC; Lee SH
Br J Dermatol; 1996 May; 134(5):949-52. PubMed ID: 8736344
[TBL] [Abstract][Full Text] [Related]
4. Localized and systemic scleroderma show different histological responses to methotrexate therapy.
Seyger MM; van den Hoogen FH; van Vlijmen-Willems IM; van de Kerkhof PC; de Jong EM
J Pathol; 2001 Apr; 193(4):511-6. PubMed ID: 11276011
[TBL] [Abstract][Full Text] [Related]
5. First case series on the use of imiquimod for morphoea.
Dytoc M; Ting PT; Man J; Sawyer D; Fiorillo L
Br J Dermatol; 2005 Oct; 153(4):815-20. PubMed ID: 16181467
[TBL] [Abstract][Full Text] [Related]
6. The roles of transforming growth factor type beta3 (TGF-beta3) and mast cells in the pathogenesis of scleroderma.
Ozbilgin MK; Inan S
Clin Rheumatol; 2003 Sep; 22(3):189-95. PubMed ID: 14505209
[TBL] [Abstract][Full Text] [Related]
7. Collagen metabolites in urine in localized scleroderma (morphoea).
Ammitzbøll T; Serup J
Acta Derm Venereol; 1984; 64(6):534-7. PubMed ID: 6084927
[TBL] [Abstract][Full Text] [Related]
8. Solitary morphoea profunda.
Whittaker SJ; Smith NP; Jones RR
Br J Dermatol; 1989 Mar; 120(3):431-40. PubMed ID: 2785401
[TBL] [Abstract][Full Text] [Related]
9. Does solitary morphoea profunda progress?
Azad J; Dawn G; Shaffrali FC; Holmes SC; Barnetson RJ; Forsyth A
Clin Exp Dermatol; 2004 Jan; 29(1):25-7. PubMed ID: 14723714
[TBL] [Abstract][Full Text] [Related]
10. Solitary fibrosing paraspinal plaque: solitary morphoea profunda?
Kirsner RS; Pardes JB; Falanga V
Br J Dermatol; 1993 Jan; 128(1):99-101. PubMed ID: 8427830
[TBL] [Abstract][Full Text] [Related]
11. Solitary morphea profunda following trauma sustained in an automobile accident.
Touloei K; Wiener A; Glick BP
Cutis; 2015 Jan; 95(1):32-6. PubMed ID: 25671442
[TBL] [Abstract][Full Text] [Related]
12. Osteoma cutis in a lesion of solitary morphoea profunda.
Julian CG; Bowers PW
Clin Exp Dermatol; 2003 Nov; 28(6):673-4. PubMed ID: 14616844
[No Abstract] [Full Text] [Related]
13. Expression of osteonectin, decorin, and transforming growth factor-beta 1 genes in fibroblasts cultured from patients with systemic sclerosis and morphea.
Vuorio T; Kähäri VM; Black C; Vuorio E
J Rheumatol; 1991 Feb; 18(2):247-51. PubMed ID: 2023219
[TBL] [Abstract][Full Text] [Related]
14. Scleroderma dermal fibroblasts overexpress vascular endothelial growth factor due to autocrine transforming growth factor β signaling.
Kajihara I; Jinnin M; Honda N; Makino K; Makino T; Masuguchi S; Sakai K; Fukushima S; Inoue Y; Ihn H
Mod Rheumatol; 2013 May; 23(3):516-24. PubMed ID: 22740248
[TBL] [Abstract][Full Text] [Related]
15. Involvement of alphavbeta5 integrin in the establishment of autocrine TGF-beta signaling in dermal fibroblasts derived from localized scleroderma.
Asano Y; Ihn H; Jinnin M; Mimura Y; Tamaki K
J Invest Dermatol; 2006 Aug; 126(8):1761-9. PubMed ID: 16675963
[TBL] [Abstract][Full Text] [Related]
16. Ultraviolet A1 phototherapy decreases inhibitory SMAD7 gene expression in localized scleroderma.
Kreuter A; Hyun J; Skrygan M; Sommer A; Tomi NS; Breuckmann F; Altmeyer P; Gambichler T
Arch Dermatol Res; 2006 Nov; 298(6):265-72. PubMed ID: 17009056
[TBL] [Abstract][Full Text] [Related]
17. Up-regulated expression of transforming growth factor beta receptors in dermal fibroblasts in skin sections from patients with localized scleroderma.
Kubo M; Ihn H; Yamane K; Tamaki K
Arthritis Rheum; 2001 Mar; 44(3):731-4. PubMed ID: 11263790
[No Abstract] [Full Text] [Related]
18. Withaferin A attenuates bleomycin-induced scleroderma by targeting FoxO3a and NF-κβ signaling: Connecting fibrosis and inflammation.
Bale S; Pulivendala G; Godugu C
Biofactors; 2018 Nov; 44(6):507-517. PubMed ID: 30367690
[TBL] [Abstract][Full Text] [Related]
19. Subcutaneous administration of polymerized type I collagen downregulates interleukin (IL)-17A, IL-22 and transforming growth factor-β1 expression, and increases Foxp3-expressing cells in localized scleroderma.
Furuzawa-Carballeda J; Ortíz-Ávalos M; Lima G; Jurado-Santa Cruz F; Llorente L
Clin Exp Dermatol; 2012 Aug; 37(6):599-609. PubMed ID: 22731679
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical expression of transforming growth factor beta3 in calcinosis in a patient with systemic sclerosis and CREST syndrome.
Kawakami T; Soma Y; Mizoguchi M; Saito R
Br J Dermatol; 2000 Nov; 143(5):1098-100. PubMed ID: 11069531
[No Abstract] [Full Text] [Related]
[Next] [New Search]
